|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1997-9-15
|
|
pubmed:abstractText |
To enhance thrombolytic responses without increasing hemorrhagic risks, the antithrombotic effects of recombinant Lys-plasminogen (r-LysPgn), a prothrombolytic plasminogen intermediate, were examined in baboon models of thrombus formation and dissolution.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0009-7322
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
5
|
|
pubmed:volume |
96
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
941-8
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:9264505-Animals,
pubmed-meshheading:9264505-Blood Vessel Prosthesis,
pubmed-meshheading:9264505-Drug Synergism,
pubmed-meshheading:9264505-Fibrinolytic Agents,
pubmed-meshheading:9264505-Male,
pubmed-meshheading:9264505-Papio,
pubmed-meshheading:9264505-Peptide Fragments,
pubmed-meshheading:9264505-Plasminogen,
pubmed-meshheading:9264505-Recombinant Proteins,
pubmed-meshheading:9264505-Stents,
pubmed-meshheading:9264505-Thrombosis,
pubmed-meshheading:9264505-Tissue Plasminogen Activator
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Reduction in stent and vascular graft thrombosis and enhancement of thrombolysis by recombinant Lys-plasminogen in nonhuman primates.
|
|
pubmed:affiliation |
Department of Medicine, Yerkes Regional Primate Research Center, Emory University School of Medicine, Atlanta, GA 30322, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|
